Adc Therapeutics SA Live Stock Price Today, Share Analysis and Chart

Name: Adc Therapeutics SA: Is Infosys Ltd. worth buying?
Item: Adc Therapeutics SA
Rating: 0.98183325
Author: Trendlyne DVM scores

about

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...

1.13 0.00 (0.00%)

77.31% Fall from 52W High

569.3K

XNYS Volume

XNYS 10 Aug, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Adc Therapeutics SA is on 13 Aug 2026 for the purpose of ADC Therapeutics SA Second Quarter Earnings Results for 2026 See details

Not Eligible

Expensive Valuation

13.8 / 100

Technically Bearish

25.4 / 100

1Yr Price target upside is 342%

3 analysts

Adc Therapeutics SA Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adc Therapeutics SA Live Stock Price Today, Share Analysis and Chart

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and ma...

77.31% Fall from 52W High

SWOT Analysis

Adc Therapeutics SA Live Price Chart

Adc Therapeutics SA Live Price Chart